Tailored formulation development for your drug product.
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
- API or formulated API in a bottle or capsule
- Immediate, modified, and sustained release tablets
- Multiparticulates, mini-tablets and granules
- Liquid filled capsules
- Orally disintegrating tablets (ODT)
- Dry powders
- Amorphous (Spray-dried, HME) dispersions
- Lipidic vehicles
- Self-emulsifying drug delivery systems (SEDDS)
- Self-micro emulsifying drug delivery systems (SMEDDS)
- Particle size reduction
With over 30 years of experience, we provide full-service support for small molecule non-sterile programs, from dosage formulation development to GMP clinical trial manufacturing and commercial drug product supply.
We focus on delivering the most appropriate formulations, however complex, to expedite your clinical program. We support rapid progression to your first-in-human evaluation and ensure that your lead drug product can be seamlessly transitioned through development and scale-up.
We have state-of-the-art, recently upgraded pharmaceutical development and clinical manufacturing facilities in the US and UK.
We have completed more than 300 drug product formulation optimization programs, involving the clinical evaluation of more than 1,000 formulations. Our unique approach to drug product optimization saves time and increases the potential for success by facilitating decisions based on real-time clinical data.
We have deep expertise in formulation development, built across more than 30 years and over 1,500 molecules developed.
Our innovative approach to formulation development is based on our proven track record in early clinical evaluation delivering phase-appropriate formulations across the product development pathway from preclinical to late-stage development.
Formulation Development Services
Explore our services and programs for small molecule & peptide drug development.